(NYSE: BHC) Bausch Health Companies's forecast annual revenue growth rate of 3.58% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.66%.
Bausch Health Companies's revenue in 2024 is $9,202,000,000.On average, 5 Wall Street analysts forecast BHC's revenue for 2024 to be $3,488,002,146,093, with the lowest BHC revenue forecast at $3,474,995,691,692, and the highest BHC revenue forecast at $3,514,363,802,613. On average, 5 Wall Street analysts forecast BHC's revenue for 2025 to be $3,613,048,393,976, with the lowest BHC revenue forecast at $3,557,887,517,932, and the highest BHC revenue forecast at $3,657,067,698,158.
In 2026, BHC is forecast to generate $3,757,977,667,070 in revenue, with the lowest revenue forecast at $3,734,988,951,646 and the highest revenue forecast at $3,788,384,062,924.